"Pyridostigmine Bromide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.
| Descriptor ID |
D011729
|
| MeSH Number(s) |
D03.383.725.762.740
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pyridostigmine Bromide".
Below are MeSH descriptors whose meaning is more specific than "Pyridostigmine Bromide".
This graph shows the total number of publications written about "Pyridostigmine Bromide" by people in this website by year, and whether "Pyridostigmine Bromide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pyridostigmine Bromide" by people in Profiles.
-
Update on the Diagnosis and Management of Acute Colonic Pseudo-obstruction (ACPO). Curr Gastroenterol Rep. 2023 Sep; 25(9):191-197.
-
Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort. Pediatr Neurol. 2021 05; 118:12-19.
-
Gulf war illness-related chemicals increase CD11b/c+ monocyte infiltration into the liver and aggravate hepatic cholestasis in a rodent model. Sci Rep. 2018 09 03; 8(1):13147.
-
Myasthenia gravis crisis. South Med J. 2008 Jan; 101(1):63-9.
-
Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases. Binocul Vis Strabismus Q. 2002; 17(3):181-6.
-
Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol. 1992 Dec; 29(12):1507-14.
-
Prednisone use in concurrent autoimmune diseases. Arch Neurol. 1979 Feb; 36(2):103-6.